CARDINAL HEALTH INC (CAH) Forecast, Price Target & Analyst Ratings

NYSE:CAH • US14149Y1082

Current stock price

205.13 USD
+2.79 (+1.38%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CARDINAL HEALTH INC (CAH).

Forecast Snapshot

Consensus Price Target

Price Target
$254.83
+ 24.23% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 30, 2026
Period
Q3 / 2026
EPS Estimate
$2.80
Revenue Estimate
62.329B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.64%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$254.83
Upside
+ 24.23%
From current price of $205.13 to mean target of $254.83, Based on 22 analyst forecasts
Low
$198.40
Median
$261.12
High
$288.75

Price Target Revisions

1 Month
1.05%
3 Months
12.78%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for CAH. The average price target is 254.83 USD. This implies a price increase of 24.23% is expected in the next year compared to the current price of 205.13.
The average price target has been revised upward by 12.78% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CAH Current Analyst RatingCAH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

CAH Historical Analyst RatingsCAH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
83.64%
CAH was analyzed by 22 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CAH.
In the previous month the buy percentage consensus was at a similar level.
CAH was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-28William BlairInitiate Outperform
2026-04-08Evercore ISI GroupMaintains Outperform -> Outperform
2026-02-24BarclaysMaintains Overweight -> Overweight
2026-02-10Wells FargoMaintains Overweight -> Overweight
2026-02-10JP MorganMaintains Neutral -> Neutral
2026-02-06MizuhoMaintains Outperform -> Outperform
2026-01-29Morgan StanleyMaintains Overweight -> Overweight
2026-01-15Wells FargoMaintains Overweight -> Overweight
2026-01-09CitigroupUpgrade Neutral -> Buy
2025-12-09BarclaysInitiate Overweight
2025-11-05Wells FargoMaintains Overweight -> Overweight
2025-11-04MizuhoMaintains Outperform -> Outperform
2025-11-03TD CowenMaintains Buy -> Buy
2025-10-31UBSMaintains Buy -> Buy
2025-10-31Evercore ISI GroupMaintains Outperform -> Outperform
2025-10-31CitigroupMaintains Neutral -> Neutral
2025-08-13Wells FargoMaintains Overweight -> Overweight
2025-08-13Evercore ISI GroupMaintains Outperform -> Outperform
2025-08-13BairdMaintains Outperform -> Outperform
2025-08-12Leerink PartnersMaintains Outperform -> Outperform
2025-07-16Morgan StanleyMaintains Overweight -> Overweight
2025-06-13Morgan StanleyMaintains Overweight -> Overweight
2025-06-13CitigroupMaintains Neutral -> Neutral
2025-06-12Evercore ISI GroupMaintains Outperform -> Outperform
2025-06-10B of A SecuritiesMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 30, 2026
Period
Q3 / 2026
EPS Estimate
$2.80
Revenue Estimate
62.329B
Revenue Q2Q
13.58%
EPS Q2Q
19.29%
Number of Analysts
17

Next Earnings Revisions

Revenue (1 Month)
-0.01%
Revenue (3 Months)
-0.88%
EPS (1 Month)
0.10%
EPS (3 Months)
2.30%

Next Earnings Summary

CAH is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is 2.8 USD and the consensus revenue estimate is 62.33B USD.
The next earnings revenue estimate has been revised downward by 0.88% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
CAH revenue by date.CAH revenue by date.
205.012B
13.04%		226.827B
10.64%		222.578B
-1.87%		261.225B
17.36%		284.893B
9.06%		307.104B
7.80%		334.857B
9.04%		362.048B
8.12%
EBITDA
YoY % growth
CAH ebitda by date.CAH ebitda by date.
2.466B
4.09%		2.86B
15.98%		3.273B
14.44%		4.086B
24.84%		4.481B
9.67%		4.893B
9.19%		5.918B
20.95%		N/A
EBIT
YoY % growth
CAH ebit by date.CAH ebit by date.
1.774B
5.78%		2.15B
21.20%		2.483B
15.49%		3.501B
41.00%		3.864B
10.37%		4.22B
9.21%		4.745B
12.44%		5.212B
9.84%
Operating Margin
CAH operating margin by date.CAH operating margin by date.
0.87%0.95%1.12%1.34%1.36%1.37%1.42%1.44%
EPS
YoY % growth
CAH eps by date.CAH eps by date.
5.81
14.82%		7.47
28.57%		8.24
10.31%		10.41
26.31%		11.69
12.35%		13.08
11.89%		14.97
14.39%		16.80
12.24%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		2.80
19.29%		2.36
13.38%		2.84
11.43%		2.95
12.04%		3.22
14.79%		2.70
14.65%		3.34
17.66%		3.40
15.34%		3.54
10.01%		3.17
17.30%
Revenue
Q2Q % growth		62.329B
13.58%		66.935B
11.26%		70.733B
10.50%		72.608B
10.64%		68.7B
10.22%		73.543B
9.87%		78.083B
10.39%		80.483B
10.85%		75.766B
10.29%		80.02B
8.81%
EBITDA
Q2Q % growth		1.036B
-21.04%		919.19M
-35.22%		1.101B
9.66%		1.116B
-12.54%		1.135B
9.56%		1.044B
13.58%		1.256B
14.08%		1.247B
11.74%		1.225B
7.93%		1.162B
11.30%
EBIT
Q2Q % growth		946.01M
29.41%		811.16M
28.96%		945.22M
22.60%		976.98M
20.76%		1.063B
12.37%		909.66M
12.14%		1.081B
14.36%		1.093B
11.88%		1.134B
6.68%		1.017B
11.80%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CAH Yearly Revenue VS EstimatesCAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100B 200B 300B
CAH Yearly EPS VS EstimatesCAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
16.66%
EPS Next 5 Year
15.31%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
10.84%
Revenue Next 5 Year
9.93%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
20.16%
EBIT Next 5 Year
20.36%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CARDINAL HEALTH INC / CAH Forecast FAQ

Can you provide the average price target for CARDINAL HEALTH INC stock?

22 analysts have analysed CAH and the average price target is 254.83 USD. This implies a price increase of 24.23% is expected in the next year compared to the current price of 205.13.

What is the next earnings date for CAH stock?

CARDINAL HEALTH INC (CAH) will report earnings on 2026-04-30, before the market open.

Can you provide the consensus estimates for CARDINAL HEALTH INC next earnings?

The consensus EPS estimate for the next earnings of CARDINAL HEALTH INC (CAH) is 2.8 USD and the consensus revenue estimate is 62.33B USD.

What is the expected long term growth rate for CARDINAL HEALTH INC (CAH)?

The expected long term growth rate for CARDINAL HEALTH INC (CAH) is 10.84%.